Novo Nordisk stock pops on Phase 1 data for new weight loss drug amycretin
Amycretin could give Novo a buzzy product in an newly competitive obesity market. It works similarly to existing GLP-1 products, by mimicking a hormone in the body that provides a satiated feeling and curbs hunger, but adds a different hormone in the pancreas.
Surprising link between sparkling water and weight loss
Maintaining a healthy weight is good for your body and can also help with self-esteem. If you’ve been trying to lose weight, ...
Don't expect to shed pounds solely due to your choice of beverage. The benefits of drinking carbonated water for weight loss ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...
One of Novo Nordisk's next-generation obesity shots to follow up on its success with Wegovy helped patients lose 22% of their ...
Gemma Collins reveals weight loss with Mounjaro injections, showcasing a new look and expressing newfound confidence.
The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...
"Drinking carbonated water can have some effects on the digestive system, particularly for individuals with sensitive stomachs or pre-existing gastrointestinal conditions," Takahashi wrote. Those ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback